Cardiovascular prevention in clinical practice (ESC and German guidelines 2007)

Herz. 2009 Feb;34(1):4-14. doi: 10.1007/s00059-009-3196-7.

Abstract

Preventive efforts should be guided by the patient's global cardiovascular (CV) risk. A risk stratification should be done in every person > age 35 with more than a single risk factor. Recommendations for improved lifestyle are applicable to all persons with CV risk factors: smoking cessation, daily exercise, normal body mass index, Mediterranean diet, blood pressure < 140 mmHg systolic, and LDL cholesterol < 130 mg/dl are beneficial. If the 10-year risk is > or = 20% for CV events or > or = 5% for CV death, additional drug interventions are usually necessary: acetylsalicylic acid 100 mg daily, statins to lower LDL cholesterol to < 100 mg/dl or, in diabetics with coronary artery disease, to < 70 mg/dl, blood pressure should be < 130 mmHg systolic, e.g., in patients with diabetes or renal disease. After bare-metal stent implantation clopidogrel should be given for > or = 4 weeks and after drug-eluting stents for > or = 6 months. In patients after myocardial infarction with an ejection fraction of < 40%, ACE inhibitors and beta-blocker should be started. Influenza vaccination improves prognosis in high-risk patients.

MeSH terms

  • Cardiology / standards*
  • Cardiovascular Diseases / diagnosis*
  • Cardiovascular Diseases / prevention & control*
  • Germany
  • Humans
  • Practice Guidelines as Topic*
  • Practice Patterns, Physicians' / standards*
  • Preventive Medicine / standards*